p-tau181
-
A-beta 42/40, Alzheimer’s disease, amyloid PET, blood biomarkers, Brain, Clarity AD, cognition, GFAP, lecanemab, maintenance dosing, Neurodegenerative Diseases, p-tau181, PK/PD modelingLecanemab Blood Biomarkers Rebound Faster Than Amyloid PET After Stopping
Lecanemab blood biomarkers may rebound much faster than amyloid PET after treatment…
